Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6

OBJECTIVE: Although the pathogenesis of non-alcoholic fatty liver disease (NAFLD) has been extensively studied, the role of its underlying pathogenesis remains unclear, and there is currently no approved therapeutic strategy for NAFLD. The purpose of this study was to observe the beneficial effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ran, Ye, Zhengqin, She, Dunmin, Fang, Ping, Zong, Guannan, Hu, Kerong, Kong, Dehong, Xu, Wei, Li, Ling, Zhou, Yun, Zhang, Keqin, Xue, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553160/
https://www.ncbi.nlm.nih.gov/pubmed/36238196
http://dx.doi.org/10.2147/DDDT.S384884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553160/
https://www.ncbi.nlm.nih.gov/pubmed/36238196
http://dx.doi.org/10.2147/DDDT.S384884

Ejemplares similares